Point-of-Care Diagnostics: Technologies and Global Markets

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	159 Pages	BCC Research	October, 2024	WA19215438

Best Price Guarantee
Price	from $5,500
Length	159 Pages
Publisher	BCC Research
Published Date	October, 2024
SKU	WA19215438

Table of Contents
Description

Point-of-Care Diagnostics: Technologies and Global Markets

Report Scope

The point-of-care diagnostics market is extensive and constantly evolving with new technologies and methodologies. This report explores the current and future market potential, competitive environment, regulatory scenario, and market trends, including projections through 2029 and an analysis of key players.

This report covers the entire industry, including hardware (devices, equipment, consumables), software, and analytics. The market is analyzed by test type, including alcohol and drug abuse, blood gas electrolyte and metabolite (BGEM), cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious disease, pregnancy and fertility, tumor markers, and urine chemistry, and it includes comprehensive regional analyses.

The report highlights ongoing R&D efforts focused on improving accuracy accessibility and incorporating innovative diagnostic procedures. It provides insights into market drivers, challenges, opportunities, industry status, developments, trends, and strategies like mergers, acquisitions, and collaborations. It is a valuable resource for market players, potential entrants, government agencies, and other stakeholders, especially those interested in geographic expansion.

Report Includes

98 data tables and 46 additional tables

An overview of the global markets and technologies for point-of-care (POC) diagnostics

Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029

Estimates of the market size and revenue forecasts for the PoC diagnostics market, with market share analysis by test type, product type, end user, and region

Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies

Coverage of government regulations and policies, R&D initiatives, exploration activities, and government programs

Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes

Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding

Profiles of the leading companies, including Abbott, BD, Danaher Corp., Thermo Fisher Scientific Inc., and F. Hoffmann-La Roche Ltd.

Companies Mentioned

ABBOTT
BD
DANAHER CORP.
GE HEALTHCARE
F. HOFFMANN-LA ROCHE LTD.
MEDTRONIC
QUEST DIAGNOSTICS INC.
QUIDELORTHO CORP.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.

Chapter 1 Executive Summary: Market Outlook; Scope of Report; Market Summary
Chapter 2 Market Overview: Overview; Novel Approaches for POC; Significance of CLIA in the United States; Regulatory Guidelines; Good Manufacturing Practice; The FDA's Role in POC Testing; Conclusion
Chapter 3 Market Dynamics: Factors Affecting the Point-of-Care Diagnostic Market; Market Drivers; High Incidences of Infectious Diseases; Growing Prevalence of Chronic Diseases; Increasing Demand for Self-Testing; Aging Population; Market Restraints; Challenges Faced by POC Manufacturers Due to Pricing Pressure; Technical Complexity; Lack of Specialized Training; Market Challenges; Challenges in Deploying Point-of-Care (POC) Diagnostics in Remote Settings; Environmental and Contamination Challenges in Point-of-Care Diagnostics; Market Opportunities; Increasing R&D Budget; Excellent Market Potential for POCT with AI and ML Integration; Emerging Economies
Chapter 4 Market Segmentation Analysis: Segmentation Breakdown; Point-of-Care Diagnostics Market, by Test Type; Drug and Alcohol Screening; Blood Gas Electrolyte and Metabolite (BGEM); Cardiac Markers; Cholesterol Testing/Monitoring; Glucose Testing and Monitoring; Infectious Disease Testing; Pregnancy and Fertility Testing; Hemoglobin and Hemostasis; Tumor Marker; Urinalysis/Urine Chemistry; Others; Point-of-Care Diagnostics Market, by Product; Hardware; Software; Point-of-Care Diagnostics Market, by End User; Hospitals and Critical Care Settings; Home Care Settings; Geographic Breakdown; Point-of-Care Diagnostics Market, by Region; North America; Europe; Asia-Pacific; Rest of the World (RoW)
Chapter 5 Emerging and Upcoming Technologies in the Market: Emerging and Upcoming Technologies; AI in Point-of-Care Diagnostics; CRISPR-Cas Systems; 3D Rapid Prototyping; Quantum Dots; RFID (Radio-Frequency Identification) and NFC (Near Field Communication); Smartphone-Based Medical Imaging; Nanomaterials in POC Devices for Pathogen Detection; Microfluidics-Based Sensing Technologies; Cloud-Integrated AI; D3 Array-UTI; EVIK DxSpheres: A Solid Assay Solution; UNIQO 160 Automated IIFT System; Recent Developments
Chapter 6 ESG Development: Introduction; Sustainability in Plastics and Bio-Based Alternatives; ESG Risk Ratings; The WHO Global Action Plan; BCC Research Viewpoint
Chapter 7 Competitive Landscape: Mergers, Acquisitions and Collaborations; Strategic Alliances; FDA Approvals; Patent Analysis; Patent Analysis, by Year; Company Share Analysis
Chapter 8 Appendix: Methodology; Sources; Abbreviations; Company Profiles; ABBOTT; BD; DANAHER CORP.; GE HEALTHCARE; F. HOFFMANN-LA ROCHE LTD.; MEDTRONIC; QUEST DIAGNOSTICS INC.; QUIDELORTHO CORP.; SIEMENS HEALTHINEERS AG; THERMO FISHER SCIENTIFIC INC.